Insider · CIK 0002038290
Ethel Rubin
Files at VNRX (VOLITIONRX LTD). First filing -, latest -.
In brief
Ethel Rubin files SEC Form 4 as director at VNRX (VOLITIONRX LTD). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Ethel Rubin has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 26, 2026 | VNRX VOLITIONRX LTD | AGrant or award Common Stock | +178,000 | $0.00 | $0 | 252,948 | Feb 27, 2026 |
| Jan 22, 2026 | VNRX VOLITIONRX LTD | AGrant or award Common Stock | +12,000 | $0.00 | $0 | 74,948 | Jan 23, 2026 |
| Aug 15, 2025 | VNRX VOLITIONRX LTD | AGrant or award Common Stock | +17,424 | $0.00 | $0 | 62,948 | Aug 19, 2025 |
| Jun 1, 2025 | VNRX VOLITIONRX LTD | AGrant or award Common Stock | +11,983 | $0.00 | $0 | 45,524 | Jun 3, 2025 |
| Dec 1, 2024 | VNRX VOLITIONRX LTD | AGrant or award Common Stock | +8,648 | $0.00 | $0 | 23,648 | Dec 3, 2024 |
Questions about Ethel Rubin
Answered from the filings on this page, as of the latest one.
Is Ethel Rubin buying or selling?
Ethel Rubin has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Ethel Rubin's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Ethel Rubin has 0.
Where does Ethel Rubin file Form 4?
Ethel Rubin has filed Form 4 at VNRX (VOLITIONRX LTD). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.